Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Vaccine|February 15, 2021
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataNathan A Serazin, Bassey Edem, Sarah R Williams, et al.
The Lancet. Infectious Diseases|May 19, 2022
Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trialSuman Kanungo, Pranab Chatterjee, Ashish Bavdekar, et al.
Journal of Global Health|September 23, 2021
Nasopharyngeal pneumococcal carriage in South Asian infants: Results of observational cohort studies in vaccinated and unvaccinated populationsAditi Apte, Girish Dayma, Hakka Naziat, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trialSubhash Thuluva, Ramesh V Matur, Subbareddy Gunneri, et al.
Vaccine|April 12, 2023
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix<sup>TM</sup> and Prevenar13<sup>TM)</sup>) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian childrenAnand Kawade, Girish Dayma, Aditi Apte, et al.
Contemporary Clinical Trials Communications|March 23, 2019
Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in IndiaAshish Bavdekar, Nandini Malshe, Latha Ravichandran, et al.
Vaccine|September 20, 2024
A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlersHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
The Pediatric Infectious Disease Journal|October 18, 2023
Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in IndiaSomnath Mangarule, Prashanth Siddaiah, Anand Kawade, et al.
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational StudyThomas Bénet, Valentina Sanchez Picot, Shally Awasthi, et al.
The Lancet. Infectious Diseases|December 3, 2013
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trialsZulfiqar A Bhutta, Maria Rosario Capeding, Ashish Bavdekar, et al.
Pageof 4